Document Detail

The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring.
MedLine Citation:
PMID:  20978247     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Adequate recovery from neuromuscular block (NMB) is imperative for the patient to have full control of pharyngeal and respiratory muscles. The train-of-4 (TOF) ratio should return to at least 0.90 to exclude potentially clinically significant postoperative residual block. Fade cannot be detected reliably with a peripheral nerve stimulator (PNS) at a TOF ratio >0.4. The time gap between loss of visual fade by using a PNS until objective TOF ratio has returned to >0.90 can be considered "the potentially unsafe period of recovery." According to our hypothesis the duration of this period would be significantly shorter with sugammadex than with neostigmine.
METHODS: Fifty patients received volatile anesthetics, opioids, and a rocuronium-induced NMB. TOF-Watch without a preload was used, but the anesthesiologist relied on visual evaluation of the TOF responses only. At end of operation, patients were randomized to receive either neostigmine 50 μg/kg or sugammadex 2 mg/kg, when 2 twitch responses were detected after the last dose of rocuronium. Timing of tracheal extubation was based on PNS and clinical data. Duration of the potentially unsafe period of recovery after reversal by either neostigmine or sugammadex was analyzed. Mann-Whitney U test and Pearson χ(2) test were used for statistical analysis.
RESULTS: The times [mean ± sd (range)] from loss of visual fade to TOF ratio >0.90 were 10.3 ± 5.5 (1.3 to 26.0) minutes and 0.3 ± 0.3 (0.0 to 1.0) minutes in the neostigmine and sugammadex groups, respectively (P < 0.001). The times from reversal by neostigmine or sugammadex to TOF ratio >0.90 were 13.3 ± 5.7 (3.5 to 28.9) and 1.7 ± 0.7 (0.7 to 3.5) minutes, respectively (P < 0.001). The values of TOF ratios at the time of loss of visual fade were 0.34 ± 0.14 (0.00 to 0.56) in patients given neostigmine and 0.86 ± 0.11 (0.64 to 1.04) in patients given sugammadex (P < 0.001).
CONCLUSIONS: There is a significant time gap between visual loss of fade and return of TOF ratio >0.90 after reversal of a rocuronium block by neostigmine. Sugammadex in comparison with neostigmine allows a safer reversal of a moderate NMB when relying on visual evaluation of the TOF response.
Hanna L Illman; Päivi Laurila; Heikki Antila; Olli A Meretoja; Seppo Alahuhta; Klaus T Olkkola
Related Documents :
20978247 - The duration of residual neuromuscular block after administration of neostigmine or sug...
18606327 - Ultrasound-guided supraclavicular brachial plexus nerve block vs procedural sedation fo...
443177 - Management of surgical complete atrioventricular block in children.
2073487 - Speed of injection does not affect subarachnoid distribution of plain bupivacaine 0.5%.
21573917 - Survival benefit of bursectomy in patients with resectable gastric cancer: interim anal...
21952927 - Early treatment of class iii malocclusion: 10-year clinical follow-up.
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2010-10-26
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  112     ISSN:  1526-7598     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-21     Completed Date:  2011-01-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  63-8     Citation Subset:  AIM; IM    
Department of Anesthesiology, Intensive Care, Emergency Care and Pain Medicine, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, PO Box 52, FI-20521 Turku, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anesthesia Recovery Period*
Double-Blind Method
Middle Aged
Monitoring, Intraoperative / methods*
Neostigmine / administration & dosage*
Neuromuscular Blockade / methods*
Time Factors
Young Adult
gamma-Cyclodextrins / administration & dosage*
Reg. No./Substance:
0/Sugammadex; 0/gamma-Cyclodextrins; 59-99-4/Neostigmine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Technical communication: respiratory variation in pulse pressure and plethysmographic waveforms: int...
Next Document:  Long-term cognitive impairment and functional disability among survivors of severe sepsis.